| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1995;25:1178-1184.)
© 1995 American Heart Association, Inc.
Articles |
From the Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (Z.A.A., E.G., H.R.K.); Department of Microbiology, University of Maryland (S.K.), College Park, Md; and Centro di Fisiologia Clinica e Ipertensione, Ospedale Maggiore, Università di Milano (Italy) (F.P.).
Correspondence to Zaid A. Abassi, PhD, Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, Bldg 10, Room 8C103, Bethesda, MD 20892-1754.
Abstract Congestive heart failure is characterized by avid sodium retention and a blunted renal response to exogenous and endogenous atrial natriuretic peptide. Inhibition of neutral endopeptidase EC 3.4.24.11, the main enzyme that degrades natriuretic peptides, produces a natriuretic response in different models of congestive heart failure. This raises the possibility that an increase in either the expression or activity of neutral endopeptidase is responsible for these phenomena. In the present study, we examined (1) the renal effects of SQ-28,603, a neutral endopeptidase inhibitor, in rats with moderate and severe congestive heart failure induced by an aortocaval fistula compared with sham controls, and (2) neutral endopeptidase expression and activity in the lungs and kidneys of these rats. Infusion of SQ-28,603 (40 mg/kg IV) induced a significant natriuretic response in normal rats and rats with moderate congestive heart failure. This response was blunted in rats with severe congestive heart failure. Surprisingly, renal neutral endopeptidase mRNA levels, assessed by quantitative reverse transcriptasepolymerase chain reaction; protein levels, assessed by Western blotting; and activity, assessed by gelatin gels, were comparable in all groups. Pulmonary neutral endopeptidase mRNA levels decreased by 45% in rats with severe congestive heart failure but not in rats with mild congestive heart failure. In addition, pulmonary neutral endopeptidase immunoreactivity levels and activity were significantly decreased in congestive heart failure in correlation with the severity of the disorder. We conclude that an increase in neutral endopeptidase expression or activity does not occur in rats with congestive heart failure, and therefore, an upregulation of neutral endopeptidase is unlikely to account for the blunted natriuretic response to the atrial natriuretic peptide and the positive sodium balance in congestive heart failure.
Key Words: membrane metallo-endopeptidase heart failure, congestive kidney lung natriuresis
This article has been cited by other articles:
![]() |
Z. A. Abassi, K. Gurbanov, S. E. Mulroney, C. Potlog, T. J. Opgenorth, A. Hoffman, A. Haramati, and J. Winaver Impaired Nitric Oxide–Mediated Renal Vasodilation in Rats With Experimental Heart Failure : Role of Angiotensin II Circulation, November 18, 1997; 96(10): 3655 - 3664. [Abstract] [Full Text] |
||||
![]() |
M. T. Rademaker, C. J. Charles, T. Kosoglou, A. A. Protter, E. A. Espiner, M. G. Nicholls, and A. M. Richards Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2372 - H2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Willenbrock, M. Scheuermann, K. Hohnel, F. C. Luft, and R. Dietz Acute and Chronic Neutral Endopeptidase Inhibition in Rats With Aortocaval Shunt Hypertension, June 1, 1996; 27(6): 1259 - 1266. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |